14
1
Growth Score
-13 pts
Heat Score
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
802319
Advanced cannabinoid-based antimicrobial technology targeting PG and MRSA.
Maxim Mikhaylov: CFO
About the Company
Naranhay Ltd is a biotechnology platform company developing patent-protected, localized antimicrobial technologies.
The platform is designed to reduce early biological risk by targeting pathogenic biofilms and microbial drivers of chronic inflammation, with initial focus on oral health (Porphyromonas gingivalis) and antimicrobial resistance
contexts (including MRSA).
Naranhay’s approach emphasizes localized intervention, regulatory scalability, and multi-segment application across oral care, medical devices, and preventive health.
